在调节瘤血管生成中的miR-29的潜力:一个全面的审查
Rui-Ting Zhou1,2,3,4, Xiao-Jie Luo1,2,5, Xiao-Xin-Ran Zhang1,2,5
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, 443002, Hubei, China.
Discover oncology
|April 6, 2025
概括
微RNAs (miRNAs),特别是miR-29,通过降低像VEGF这样的关键生长因子来抑制瘤血管生成. 这一发现突出了miR-29作为癌症治疗的潜在治疗点.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 微RNAs (miRNAs) 是基因表达的关键调节者.
- miRNAs涉及各种与瘤相关的生物过程.
- miR-29因其在调节瘤血管生成中的重要作用而得到认可.
研究的目的:
- 研究miR-29在调节瘤血管生成中的作用.
- 探索miR-29表达与瘤恶性之间的相关性.
- 确定参与血管生成的miR-29的直接点.
主要方法:
- 双露西法酶记者测定证实了mRNAs的直接向.
- 分析miR-29表达与血管新生和人类瘤恶性瘤的相关性.
- 使用瘤细胞系和动物模型进行的实验,具有miR-29过度表达和下调.
主要成果:
- miR-29与瘤血管生成和恶性瘤有负相关性.
- miR-29直接针对VEGF,PDGF和MMP-2mRNA的3'-未翻译区域 (UTR).
- 过度表达miR-29抑制了血管生成,而其下调则促进了血管生成.
结论:
- miR-29在抑制瘤血管生成方面发挥着至关重要的作用.
- miR-29能够准多种亲血管性因素,使其成为一个有前途的治疗候选者.
- 核酸疗法的进步可能会促进基于miR-29的抗血管生成策略.
相关概念视频
Mechanism of Angiogenesis
5.1K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.1K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K


